iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionPrestige Wealth Management Group LLC
Latest Disclosed Ownership159 shares
Latest Disclosed Value $ 26,848
Prestige Wealth Management Group LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On May 13, 2026 - Prestige Wealth Management Group LLC filed a 13F-HR form disclosing ownership of 159 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $26,848 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 159 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $20,837 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 159 0 0.00 27 0.00 0.0053
2026-02-11 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 159 0 0.00 27 18.18 0.0051
2026-02-20 2025-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 159 0 0.00 23 10.00 0.0044
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 159 0 23 0.0044
2026-02-20 2025-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 159 0 0.00 20 0.00 0.0041
2025-08-14 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 159 0 20 0.0041
2026-02-20 2025-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 159 -60 -27.40 20 -28.57 0.0043
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 159 -60 20 0.0043
2026-02-20 2024-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 29 -9.68 0.0060
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 29 0.0060
2026-02-20 2024-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 32 3.33 0.0066
2024-11-15 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 32 0.0066
2026-02-20 2024-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 30 0.00 0.0065
2024-08-06 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 30 0.0065
2024-04-26 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 30 3.45 0.0065
2024-04-26 2023-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 30 11.54 0.0068
2024-02-08 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 30 0.0056
2024-04-26 2023-09-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 0 0.00 27 -3.70 0.0066
2023-11-14 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 219 0 27 0.0066
2024-04-26 2023-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 219 -4 -1.79 28 -3.57 0.0066
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 219 -4 28 0.0066
2024-04-26 2023-03-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 223 -32 -12.55 29 -15.15 0.0072
2023-05-16 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 223 -32 29 0.0071
2023-02-08 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 255 -87 -25.44 33 -17.50 0.0087
2022-11-01 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 342 -10 -2.84 40 -2.44 0.0112
2022-08-10 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 352 -19,894 -98.26 41 -98.45 0.0111
2022-05-05 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 20,246 651 3.32 2,638 -11.80 0.6492
2022-02-15 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 19,595 1,899 10.73 2,991 4.54 0.7147
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,696 672 3.95 2,861 2.69 0.7323
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,024 7 0.04 2,786 8.74 0.7396
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 17,017 436 2.63 2,562 1.99 0.7005
2021-02-17 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 16,581 4,620 38.63 2,512 55.06 0.6884
2020-10-26 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 11,961 11,961 1,620 0.4893
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -10 -100.00 0 -100.00
2020-01-28 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 10 10 1 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.